Roche Holding AG (RHHVF)
449.03
-15.16
(-3.27%)
USD |
OTCM |
Mar 05, 16:00
Roche Cash from Investing (TTM) : -10.89B for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Galderma Group AG | -220.95M |
| EvoNext Holdings SA | 4.034M |
| Kuros Biosciences Ltd. | -1.824M |
| Basilea Pharmaceutica AG | -3.579M |